Division of Nephrology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Division of Nephrology and Hypertension, Department of Internal Medicine, Inha University, College of Medicine, Incheon, Korea.
Sci Rep. 2019 Dec 3;9(1):18156. doi: 10.1038/s41598-019-54191-1.
The optimal vascular access type for elderly hemodialysis patients is controversial. We evaluated the impact of comorbidity burden on the association between vascular access type and mortality risk among 23,100 hemodialysis patients aged ≥65 years from the Korean Society of Nephrology End-Stage Renal Disease registry data. Subjects were stratified into tertiles according to the simplified Charlson comorbidity index (sCCI), and the survival and hospitalization rates were compared with respect to vascular access type: arteriovenous fistula (AVF), arteriovenous graft (AVG), and central venous catheter (CVC). Among all tertiles of sCCI, CVC use showed highest risk of mortality than AVF use. In the lowest to middle tertile, no difference was observed in survival rates between the use of AVF and AVG. However, in the highest tertile, AVG use showed higher risk of mortality than AVF use. When subjects were classified according to a combination of sCCI tertile and access type (AVF vs. AVG), patients with the highest CCI with AVG showed 1.75-folded increased risk of mortality than those with the lowest sCCI with AVF. Hospitalization rates due to access malfunction were highest in patients with CVC in all sCCI tertiles. In the highest tertile, patients with AVG showed increased rates of hospitalization compared to those with AVF due to access malfunction. However, hospitalization rates due to access infection were highest in patients with AVG in all tertiles. The use of AVF may be of benefit and switching to AVF should be considered in elderly hemodialysis patients with a high burden of comorbidity.
对于老年血液透析患者,最佳的血管通路类型仍存在争议。我们评估了共病负担对韩国肾脏病学会终末期肾脏病登记数据中 23100 名≥65 岁血液透析患者血管通路类型与死亡率之间关联的影响。根据简化 Charlson 共病指数(sCCI),将受试者分为三分位组,并比较了血管通路类型(动静脉瘘 [AVF]、动静脉移植物 [AVG] 和中心静脉导管 [CVC])的生存率和住院率。在所有 sCCI 三分位组中,CVC 的使用与 AVF 的使用相比,死亡风险最高。在最低到中间三分位组中,AVF 和 AVG 的使用在生存率方面没有差异。然而,在最高三分位组中,AVG 的使用与 AVF 的使用相比,死亡风险更高。当根据 sCCI 三分位和通路类型(AVF 与 AVG)对受试者进行分类时,sCCI 最低的 AVF 患者与 sCCI 最高的 AVG 患者相比,死亡风险增加了 1.75 倍。在所有 sCCI 三分位组中,CVC 患者因通路功能障碍导致的住院率最高。在最高三分位组中,由于通路功能障碍,与 AVF 患者相比,AVG 患者的住院率增加。然而,在所有三分位组中,AVG 患者的感染相关住院率最高。在共病负担高的老年血液透析患者中,使用 AVF 可能有益,应考虑将其转换为 AVF。